We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BRPT:IDXPT Barito Pacific Tbk Analysis

Data as of 2026-07-07 - not real-time

IDR 1,580.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Barito Pacific is trading around IDR 1,580, just below its 20‑day SMA (1,583.5) and well under the 50‑day (1,754.7) and 200‑day (2,567.2) averages, indicating a short‑term pull‑back within a longer‑term bearish framework. The RSI sits near 49, suggesting neutral momentum, while the MACD histogram is positive and the signal line is bullish, hinting at a possible technical bounce. Support sits at IDR 1,270 and resistance at IDR 1,915, framing a modest upside range of roughly 20% before hitting the next barrier. Volatility is extreme at 127% over the past 30 days, and trading volume has been decreasing, which amplifies price swings.
Fundamentally, the company posts modest revenue growth of 2.3% and thin profit margins (≈6%), but carries a heavy debt load (debt‑to‑equity >130%) and negative free cash flow, raising concerns about financial flexibility. Valuation multiples are sky‑high – PE ~14.5, PB ~63,200 and price‑to‑sales >15,000 – and a discounted cash flow model flags a fair value far below the market price, signaling clear overvaluation. ROE is strong at 35%, yet the dividend payout is zero with a meager yield of 0.11%, questioning dividend sustainability. The sector (basic materials – chemicals) is cyclical and subject to regulatory and commodity price swings, while Indonesia‑specific risks remain moderate. Overall, the stock appears overvalued with high volatility but retains a modest upside potential if technical momentum resurfaces and the balance sheet stabilises.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Bullish MACD signal despite bearish trend
  • Price near support with room to test resistance
  • High short‑term volatility offering entry opportunities

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Overvalued multiples and heavy debt burden
  • Negative free cash flow limiting operational flexibility
  • Neutral momentum indicators (RSI near 50)

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong ROE indicating efficient capital use
  • Diversification into renewable energy projects
  • Potential upside if balance sheet deleverages and cash flow improves

Key Metrics & Analysis

Financial Health

Revenue Growth232.20%
Profit Margin5.98%
P/E Ratio14.5
ROE34.82%
ROA0.98%
Debt/Equity133.91
P/B Ratio63200.0
Op. Cash FlowIDR413.9M
Free Cash FlowIDR-1247792384

Technical Analysis

TrendBearish
RSI49.3
SupportIDR 1,270.00
ResistanceIDR 1,915.00
MA 20IDR 1,583.50
MA 50IDR 1,754.70
MA 200IDR 2,567.15
MACDBullish
VolumeDecreasing
Fear & Greed Index93.11

Valuation

Fair ValueIDR 0.06
Target PriceIDR 2,554.52
Upside/Downside61.68%
GradeOvervalued
TypeValue
Dividend Yield0.11%

Risk Assessment

Beta0.52
Volatility126.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.